Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-20-057068

Chief Financial Officer sold 10,000 shares at an average $136.57 ($1,365,723)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

McAnear Justin J. · Chief Financial Officer

Table I: Non-derivative

11 lines
Date Transaction Shares Price Value Owned after D/I
2020-11-02 Exercise or conversion : show line 1 in the form +7,100 $5.04 $35,784 8,033 D
2020-11-02 Sale : show line 2 in the form −1,324 $135.40 $179,264 6,709 D
2020-11-02 Sale : show line 3 in the form −4,376 $136.10 $595,581 2,333 D
2020-11-02 Sale : show line 4 in the form −500 $137.10 $68,552 1,833 D
2020-11-02 Sale : show line 5 in the form −500 $137.99 $68,995 1,333 D
2020-11-02 Sale : show line 6 in the form −400 $139.21 $55,684 933 D
2020-11-03 Exercise or conversion : show line 7 in the form +2,900 $5.04 $14,616 3,833 D
2020-11-03 Sale : show line 8 in the form −200 $135.55 $27,110 3,633 D
Open-market sales · 10,000 sh · avg $136.57 · $1,365,723

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-11-02 Exercise or conversion : show line 12 in the form Stock Option (right to buy) −7,100 $5.04 2028-11-02 7,100 512,900 D
2020-11-03 Exercise or conversion : show line 13 in the form Stock Option (right to buy) −2,900 $5.04 2028-11-02 2,900 510,000 D
Loading xslF345X03/doc4.xml…